Overview

High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
High Risk Population of Cardiovascular Disease in Hubei Province (Coronary Heart Disease With Diabetes) Screening and Intervention Program(CCDInT)is a randomized controlled study to verify that protocol treatment group is more effective than the conventional treatment group in reducing the incidence of composite cardiovascular disease (cardiovascular death, non fatal myocardial infarction, non fatal stroke, hospitalization for heart failure, and readmission for acute coronary syndrome) in patients with coronary heart disease and type 2 diabetes.
Phase:
N/A
Details
Lead Sponsor:
Wuhan Union Hospital, China
Collaborator:
Peking University First Hospital
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors
Glucagon
Glucagon-Like Peptide 1